Director, Financial Planning And Analysis (fp&a)

Magnolia Medical Technologies has a unique opportunity for a Director, Financial Planning and Analysis (FP&A) to join our talented team in Finance and Accounting.  The Director FP&A will partner closely with our CFO to work directly with leadership across the organization on KPIs in support of the current strategic plan and advise with analysis and insights to achieve success.  This role will lead the long term financial planning process and annual operating plan and drive the financial aspect of mission-critical initiatives across the business. 

About Us

Magnolia Medical Technologies is a commercial-stage medical device company that is developing solutions to challenges that have long plagued our healthcare system. Our Steripath® Initial Specimen Diversion Device® for blood collection and contamination prevention has created a new standard of care for prevention of false positive blood cultures, the gold standard diagnostic test for sepsis.

Steripath delivers significant clinical and cost savings benefits which have been extensively proven with large bodies of clinical data and peer-reviewed published studies. Based on this exceptional performance profile, we have an exclusive FDA-cleared indication for reducing blood culture contamination and uniquely provide a money-back Clinical Performance Guarantee for Steripath to our hospital customers.

With strong institutional investor backing, we offer highly committed and qualified candidates the opportunity to be a part of building a company dedicated to dramatically improving the accuracy of sepsis diagnostics to positively impact patient outcomes and hospital economics.

Position Summary

The Director, Financial Planning & Analysis will play a key role with the department leadership together with the CFO, having responsibility for day-to-day oversight of the function including the management and development of the annual operating plan, the quarterly forecasting and monthly business reviews.  Working collaboratively with department leaders and managers, provides ongoing financial and analytic support and is the SME for operations, supply chain and manufacturing financial activity internally and with our CMs.  Leveraging our ERP, will continue to manage  all aspects of financial analytics, reporting and system design/optimization (including areas of revenue, margins, department-level budgeting & reconciliation, cash flow analysis, etc.).

In this role, the Director FP&A will participate in decision making, considering and communicating variance, implications in terms of legal, tax, human capital processes, and change management all the while able to work strategically as well as engage in the details.

Responsibilities and Duties:

• Development of strategic plans and detailed budget needs (personnel/capital/specific initiatives/other) at both the individual department and top-line corporate level

• Manage, monitor and evaluate project spend and cash management with department heads, with timely and accurate variance reporing

• Consolidation of all monthly, quarterly, and annual results vs. plan and/or most recent forecast

• Accurate development and reporting of synthesized key performance indicators (KPIs) with analysis that allow CFO and Sr Leaders review of key factors that provide insight to identify risks, opportunities and gaps to forecast and plan

• Identify and recommend action plans to navigate findings that mitigate risk and/or maximize on opportunities

• Drive innovation and standardization in continuous streamlining of the the forecast, planning and reporting processes; identifying best practice and efficiency of routing tasks and reporting

• Alignment with Revenue Operations as needed to analyze revenue and assist with evolution of efficient and effective reporting and dashboards to enable predictive forecasting and results analysis

• Working collaboratively with leadership, develop and implement capital efficiency-based metrics to help quantify ROIs on operating expense investments to drive growth

• Partner with IT and systems administrators to enable effective tools for management to obtain financial insights on a timely basis

• Provides team leadership to develop and implement key controls around our financial statements and forecasting

• Performs other duties as assigned.

Experience and Qualifications:

• Bachelor’s degree in business, finance or accounting with a working knowledge of accounting and strong foundational experience in financial planning and analysis.

• At least 10 years’ experience working in a corporate finance organization. Medical device manufacturing experience a plus.

• Demonstrated financial modeling and presentation skills.

• Working experience within Salesforce and Microsoft Dynamics. General knowledge and passion to work with enterprise systems a must.

• Excellent verbal and written communication skills, including active listening.

• Enjoys building relationships with team members at all levels within the organization. Passion for

supporting employees.

• Flexible and adaptable to changing situations and needs, operating effectively in ambiguity.
• Ability to manage time and resources effectively and productively, prioritize workload, and meet

deadlines.

• Given access to sensitive information, strict adherence to confidentiality and discretion

About Magnolia Medical Technologies, Inc.

Magnolia Medical Technologies develops, manufactures and markets innovative blood and bodily fluid collection devices to facilitate significant improvements in the accuracy, consistency and predictability of critical laboratory tests for patients in hospitals.

Dr. Richard Patton, the company’s co-founder, invented and patented the Initial Specimen Diversion Technique (ISDT™) and Initial Specimen Diversion Device (ISDD®) for blood culture collection and contamination prevention, and authored the seminal peer-reviewed publication on the efficacy of this technique the Journal of Clinical Microbiology in 2010.

The company’s flagship product, Steripath® Initial Specimen Diversion Device® for blood culture collection and contamination prevention, has been clinically proven in over 20 studies including 8 peer-reviewed publications in leading medical journals to virtually eliminate the preventable error of blood culture contamination and false positive results for the diagnosis of sepsis. Steripath delivers reductions in false positives of up to 92% with 12-month sustained contamination rates as low as 0.2% and an average cost savings of ~$1M a year for a typical US hospital.

Magnolia is establishing the new standard for blood culture integrity and sepsis testing accuracy and has effectively executed against its mission to change national blood culture collection guidelines and contamination benchmarks through CDC, CLSI and NQF.

The company has amassed an intellectual property portfolio including more than 125 issued method, apparatus and design patents with more than 50 additional patent applications pending.

Magnolia Medical is committed to the continued development and successful marketing of innovative products that will transform the way healthcare is practiced around the world.  The company supports this effort by offering competitive compensation, incentive packages, benefits and career growth opportunities to the most qualified candidates in the marketplace. Magnolia Medical Technologies, Inc. is an equal opportunity employer.

For more information, visit magnolia-medical.com

For more information, visitmagnolia-medical.com

**As a condition of employment with Magnolia Medical Technologies, you are required to provide proof that you are fully vaccinated against COVID-19 or qualify for a reasonable accommodation.